サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1764955

アジア太平洋の末梢塞栓用コイルの2031年までの市場予測-地域別分析-タイプ別、材料別、用途別

Asia Pacific Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application

出版日
ページ情報
英文 126 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
アジア太平洋の末梢塞栓用コイルの2031年までの市場予測-地域別分析-タイプ別、材料別、用途別
出版日: 2025年04月14日
発行: The Insight Partners
ページ情報: 英文 126 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の末梢塞栓用コイル市場は、2023年に1億3,845万米ドルと評価され、2031年には2億452万米ドルに達すると予測され、2023～2031年のCAGRは5.0%と推定されます。

塞栓コイルの応用範囲の拡大がアジア太平洋の末梢塞栓コイル市場を後押し

末梢塞栓用コイル市場で事業を展開する企業は、新製品の上市やマーケティングの承認に常に注力し、売上向上に貢献しています。末梢塞栓用コイル市場における注目すべき市場の開拓を以下に発表します。2024年1月、Zylox-Tonbridge Medical Technology Co Ltd.が製造したZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization Systemが国家医療製品管理局から販売承認を取得しました。末梢血管インターベンションは、この塞栓コイルシステムの最も一般的な用途です。内臓動脈瘤の塞栓治療、腹部大動脈瘤のエンドリーク管理、喀血、動静脈瘻はこのシステムの他の重要な臨床応用であり、その安全性と有効性は国際的に認められています。2022年4月、ボストン・サイエンティフィック・コーポレーションは、末梢血管の血流量を遮断または減少させるために設計されたEMBOLDファイバー着脱式コイルについて、米国食品医薬品局（FDA）より510（k）クリアランスを取得しました。ボストン・サイエンティフィックのインターベンショナルオンコロジー・ポートフォリオに新たに加わったこの製品は、様々な塞栓術、すなわち1本以上の血管を塞いで血流を阻害または減少させることを目的とした必ずしも低侵襲な治療で使用するために設計されました。EMBOLD Fibered Detachable Coilは、3つのコイルで構成される単一のプラットフォームを特徴としており、医師が様々な患者のニーズや解剖学的構造に対応することをより簡単にしています。このように、新製品開発と販売承認は、予測期間中に末梢塞栓用コイル市場の成長機会を創出すると予想されます。

アジア太平洋の末梢塞栓用コイル市場概要

アジア太平洋の末梢塞栓用コイル市場は、中国、インド、日本、韓国、オーストラリア、その他のアジア太平洋のに区分されます。この地域の市場成長は、医療インフラが継続的に進歩していること、欧州の各国で腹部大動脈瘤、急性消化管出血（AGIB）、腫瘍の発生率が高いことに起因しています。2022年4月にBMC Public Healthに掲載された紙製によると、中国における大動脈瘤の疾病負担は1990～2020年にかけて劇的に増加し、男性、高齢者集団、西部の省の住民の死亡率が高くなっています。一般的な疾患である下肢静脈瘤は、インド人口の30％、特に女性が罹患しています。この疾患は長期に渡って開発され、出血、凝固、潰瘍などの合併症を引き起こし、患者の生活の質に影響を与えます。静脈瘤の患者は深部静脈血栓症を発症しやすいです。なぜなら、静脈のうっ滞や損傷はしばしば表在性静脈炎を引き起こし、その静脈炎は穿通動脈を介して広がり、深部静脈系に侵入する可能性があるからです。

国立がん研究センターによると、日本では2022年に100万人以上の新規腫瘍患者と38万400人の腫瘍関連死亡者を記録しました。大腸がん、胃がん、肺がん、前立腺がんは日本で最も頻度の高いがんで、がん患者全体の45％以上を占めます。日本における前立腺がんの診断は、過去10年間で1.8倍に増加しました。様々な危険因子、特に人口の高齢化により、膨大な数の人々ががんと診断され、前立腺がんの症例が急増しています。AGIBは、高い罹患率と死亡率を有する一般的な救急疾患です。上部消化管出血（UGIB）と下部消化管出血（LGIB）に分けられ、それによって患者の評価と治療の方針が決まる。クイーンズランド州政府によると、オーストラリアでは、UGIBは人口10万人あたり年間50～150人が罹患し、致死率は6～8％です。同じ情報源によると、オーストラリアではLGIBの症例に関するデータはないといわれています。NIHが発表した紙製によると、2023年、外傷は韓国の主要死因の第3位で、死亡率全体の9.2％を占めています。外傷は若年層に多く、男性の報告例は女性の2倍です。韓国の予防可能な院内外傷致死率は他の先進諸国よりも高く、5％から10％です。

アジア太平洋の末梢塞栓用コイル市場の収益と2031年までの予測（金額）

アジア太平洋の末梢塞栓用コイル市場セグメンテーション

アジア太平洋の末梢塞栓用コイル市場は、タイプ、材料、用途、国に分類されます。

タイプ別では、アジア太平洋の末梢塞栓用コイル市場は着脱式コイルとプッシャブルコイルに二分されます。2023年には着脱式コイルセグメントがより大きな市場シェアを占めています。

材料別では、アジア太平洋の末梢塞栓用コイル市場は、プラチナ、プラチナ&ハイドロゲル、プラチナタングステン合金に分類されます。2023年にはプラチナセグメントが最大の市場シェアを占めています。

用途別では、アジア太平洋の末梢塞栓用コイル市場は、出血と外傷、奇形、腫瘍、内臓動脈瘤、エンドリークII型、静脈瘤に区分されます。出血＆外傷セグメントが2023年に最大の市場シェアを占めました。

国別に見ると、アジア太平洋の末梢塞栓用コイル市場は、中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋のに区分されます。2023年のアジア太平洋の末梢塞栓用コイル市場シェアは中国が独占しています。

Medtronic Plc、Penumbra, Inc、Balt、Boston Scientific Corp、Cook Medical Holdings LLC、Wallaby Medical、Spartan Micro Inc、ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY、LTD、Terumo Corp、and NeuroSafe Medical Co.Ltd.などがアジア太平洋の末梢塞栓用コイル市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察
  • 市場の魅力

第3章 調査手法

  • 二次調査
  • 一次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 アジア太平洋の末梢塞栓用コイル市場：主要市場力学

  • 市場促進要因
    • 大動脈瘤の有病率の上昇
    • がんの発生率の増加
  • 市場抑制要因
    • 塞栓術の実施中または実施後に発生する合併症
  • 市場機会
    • 塞栓用コイルの応用範囲の拡大
  • 今後の動向
    • 充填密度の重要性の高まり
  • 促進要因と抑制要因の影響

第5章 末梢塞栓用コイル市場：アジア太平洋の分析

  • アジア太平洋の末梢塞栓用コイル市場概要
  • 末梢塞栓用コイルの市場収益（2021～2031年）
  • 末梢塞栓用コイルの市場予測分析
  • 末梢塞栓用コイル市場企業のポジショニング

第6章 アジア太平洋の末梢塞栓用コイル市場分析-製品タイプ別

  • イントロダクション
  • 着脱式コイル
  • プッシャブルコイル

第7章 アジア太平洋の末梢塞栓用コイルの市場分析-材料別

  • イントロダクション
  • プラチナ
  • プラチナ＆ハイドロゲル
  • 白金タングステン合金

第8章 アジア太平洋の末梢塞栓用コイルの市場分析-用途別

  • イントロダクション
  • 出血と外傷
  • 奇形
  • 腫瘍
  • 内臓動脈瘤
  • エンドリークII型
  • 静脈瘤

第9章 アジア太平洋の末梢塞栓用コイル市場：国別分析

  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他のアジア太平洋

第10章 末梢塞栓用コイル市場-産業情勢

  • イントロダクション
  • 末梢塞栓用コイル市場における成長戦略
  • 無機的成長戦略
    • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Medtronic Plc
  • Penumbra, Inc.
  • Balt
  • Boston Scientific Corp
  • Cook Medical Holdings LLC
  • Wallaby Medical
  • Spartan Micro Inc.
  • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
  • Terumo Corp
  • NeuroSafe Medical Co. Ltd

第12章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Peripheral Embolization Coils Market Segmentation
  • Table 2. Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 4. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 5. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 6. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 7. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 8. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 9. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 10. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 11. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 12. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 13. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 14. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 15. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 16. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 17. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 18. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 19. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 20. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 21. Recent Inorganic Growth Strategies in the Peripheral Embolization Coils Market
  • Table 22. Recent Organic Growth Strategies in the Peripheral Embolization Coils Market
  • Table 23. Glossary of Terms, Peripheral Embolization Coils Market

List Of Figures

  • Figure 1. Asia Pacific Peripheral Embolization Coils Market Segmentation, by Country
  • Figure 2. Peripheral Embolization Coils Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
  • Figure 5. Company Positioning
  • Figure 6. Peripheral Embolization Coils Market Share (%) - by Product Type (2023 and 2031)
  • Figure 7. Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Peripheral Embolization Coils Market Share (%) - by Material (2023 and 2031)
  • Figure 10. Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Peripheral Embolization Coils Market Share (%) - by Application (2023 and 2031)
  • Figure 14. Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Asia Pacific: Peripheral Embolization Coils Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 21. Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 22. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Growth Strategies in the Peripheral Embolization Coils Market
目次
Product Code: BMIRE00031512

The Asia Pacific peripheral embolization coils market was valued at US$ 138.45 million in 2023 and is expected to reach US$ 204.52 million by 2031; it is estimated to register a CAGR of 5.0% from 2023 to 2031.

Expanding Range of Applications of Embolization Coils Boosts Asia Pacific Peripheral Embolization Coils Market

Companies operating in the peripheral embolization coils market constantly focus on new product launches and marketing approval, which helps them improve their sales. A few of the noteworthy developments in the peripheral embolization coils market are mentioned below. In January 2024, the National Medical Products Administration provided marketing approval for the ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System manufactured by Zylox-Tonbridge Medical Technology Co Ltd. Peripheral vascular intervention is the most prevalent application of this embolization coil system. Embolization treatment of visceral aneurysms, endoleak management of abdominal aortic aneurysms, hemoptysis, and arteriovenous fistula are the other important clinical applications of the system, which are internationally recognized for their safety and efficacy. In April 2022, Boston Scientific Corporation received 510(k) clearance from the US Food and Drug Administration (FDA) for the EMBOLD Fibered Detachable Coil designed to block or reduce the blood flow rate in the peripheral vasculature. The newest addition to Boston Scientific's interventional oncology portfolio was designed for use in various embolization procedures, necessarily minimally invasive treatments intended to block one or more blood vessels to obstruct or reduce blood flow. The EMBOLD Fibered Detachable Coil features a single platform consisting of three coils, making it simpler for physicians to address various patient needs and anatomies. Thus, new product developments and marketing approvals are anticipated to create opportunities for growth of the peripheral embolization coils market during the forecast period.

Asia Pacific Peripheral Embolization Coils Market Overview

The Asia Pacific peripheral embolization coil market is segmented into China, India, Japan, South Korea, Australia, and Rest of Asia Pacific. Market growth in this region is ascribed to the continuously advancing healthcare infrastructure, and the significant incidence of abdominal aortic aneurysms, acute gastrointestinal bleeding (AGIB), and tumors in different European countries. According to an article published in BMC Public Health in April 2022, the disease burden of aortic aneurysms in China increased dramatically from 1990 to 2020, with greater mortality rates among men, elderly populations, and residents of western provinces. Varicose veins, a common condition, affect 30% of the Indian population, particularly women. Conditions can develop over time, resulting in complications such as bleeding, clotting, and ulceration that impact the quality of life of patients. Patients with varicose veins are highly susceptible to developing deep vein thrombosis because venous stasis and damage often result in superficial phlebitis, which can spread through perforating arteries and enter the deep venous system.

According to the National Cancer Centre of Japan, the country recorded more than 1million new tumor cases and 380,400 tumor-related deaths in 2022. Colorectal, stomach, lung, and prostate tumors are the most frequent cancers in Japan, accounting for over ~45% of all cancer cases. Prostate cancer diagnoses in Japan have increased 1.8 times in the last decade. A vast number of people are being diagnosed with cancer caused by a variety of possible risk factors, most notably population aging, and the cases of prostate cancer are surging at a rapid pace. AGIB is a common emergency condition with high morbidity and death rates. It is divided into upper gastrointestinal bleeding (UGIB) and lower gastrointestinal bleeding (LGIB), which determine the course of patient evaluation and treatment. According to the Queensland Government, in Australia, UGIB affects 50-150 individuals per 100,000 people per year, with a 6-8% fatality rate. The same source also states that there is no data is available on LGIB cases in Australia. According to an article published by NIH, in 2023, traumatic injuries ranked third among the leading causes of death in South Korea, accounting for 9.2% of the total mortality. Trauma is more common in younger people, and the cases reported in men are twice those in women. South Korea has a higher preventable in-hospital trauma fatality rate than other developed countries, which ranges from 5% to 10%.

Asia Pacific Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Peripheral Embolization Coils Market Segmentation

The Asia Pacific peripheral embolization coils market is categorized into type, material, application, and country.

Based on type, the Asia Pacific peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.

In terms of material, the Asia Pacific peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.

By application, the Asia Pacific peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.

Based on country, the Asia Pacific peripheral embolization coils market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific peripheral embolization coils market share in 2023.

Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO.; LTD.; Terumo Corp; and NeuroSafe Medical Co. Ltd. are among the leading companies operating in the Asia Pacific peripheral embolization coils market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Peripheral Embolization Coils Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rise in Prevalence of Aortic Aneurysm
    • 4.1.2 Increase in Incidence of Cancer
  • 4.2 Market Restraints
    • 4.2.1 Complications Arising During or After Embolization
  • 4.3 Market Opportunities
    • 4.3.1 Expanding Range of Applications of Embolization Coils
  • 4.4 Future Trends
    • 4.4.1 Growing Importance of Packing Density
  • 4.5 Impact of Drivers and Restraints:

5. Peripheral Embolization Coils Market - Asia Pacific Analysis

  • 5.1 Asia Pacific Peripheral Embolization Coils Market Overview
  • 5.2 Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
  • 5.3 Peripheral Embolization Coils Market Forecast Analysis
  • 5.4 Peripheral Embolization Coils Market: Company Positioning

6. Asia Pacific Peripheral Embolization Coils Market Analysis - by Product Type

  • 6.1 Overview
  • 6.2 Detachable Coil
    • 6.2.1 Overview
    • 6.2.2 Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Pushable Coil
    • 6.3.1 Overview
    • 6.3.2 Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Peripheral Embolization Coils Market Analysis - by Material

  • 7.1 Overview
  • 7.2 Platinum
    • 7.2.1 Overview
    • 7.2.2 Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Platinum & Hydrogel
    • 7.3.1 Overview
    • 7.3.2 Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Platinum Tungsten Alloy
    • 7.4.1 Overview
    • 7.4.2 Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Peripheral Embolization Coils Market Analysis - by Application

  • 8.1 Overview
  • 8.2 Bleedings & Trauma
    • 8.2.1 Overview
    • 8.2.2 Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Malformations
    • 8.3.1 Overview
    • 8.3.2 Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Tumors
    • 8.4.1 Overview
    • 8.4.2 Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Visceral Aneurysms
    • 8.5.1 Overview
    • 8.5.2 Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Endoleak Type II
    • 8.6.1 Overview
    • 8.6.2 Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.7 Varicose Veins
    • 8.7.1 Overview
    • 8.7.2 Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Peripheral Embolization Coils Market - Country Analysis

  • 9.1 Asia Pacific: Market Overview
    • 9.1.1 Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Key Country, 2023 and 2031 (%)
      • 9.1.1.1 China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.1.1 China: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.1.2 China: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.1.3 China: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.2 Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.2.1 Japan: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.2.2 Japan: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.2.3 Japan: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.3 India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.3.1 India: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.3.2 India: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.3.3 India: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.4 Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.4.1 Australia: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.4.2 Australia: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.4.3 Australia: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.5 South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.5.1 South Korea: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.5.2 South Korea: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.5.3 South Korea: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.6 Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.6.1 Rest of Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.6.2 Rest of Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.6.3 Rest of Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Application

10. Peripheral Embolization Coils Market-Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Peripheral Embolization Coils Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Penumbra, Inc.
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Balt
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Boston Scientific Corp
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Cook Medical Holdings LLC
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Wallaby Medical
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Spartan Micro Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Terumo Corp
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 NeuroSafe Medical Co. Ltd
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms